Resources

Keep up to date with us.

On-Demand Webinars

Learn about the latest advances in assessing and managing liver disease, featuring key opinion leaders and subject matter experts.

Key Takeaways from AASLD 2024

December 17, 2024, 9AM PT

Liver health experts Dr. Naim Alkhouri and patient advocate Michael Betel share highlights and key insights from the world’s leading forum on liver disease!

Learn More

Stay Informed

Find our latest news and company updates. For all media inquiries, contact us at communications@sonicincytes.com.

Liver Elastography: CPT Codes, Common Mistakes & Best Practices for Billing

Ensuring proper use of CPT codes for liver elastography not only facilitates smooth reimbursements but also helps avoid unnecessary claim

FDA Grants 510(k) Clearance to Sonic Incytes’ Velacur® Determined Fat Fraction (VDFF), a breakthrough for patients with MASLD and MASH

VANCOUVER, British Columbia — (BUSINESS WIRE) — Sonic Incytes Medical Corp, a leader in point-of-care ultrasound, proudly announces that the

Capital Digestive Care increases liver elastography volume by 171% with Velacur

FATTY LIVER DISEASE Fatty liver disease is the fastest-growing segment of chronic liver disease, with an estimated one in three

Sonic Incytes Recognized at 2023 LSBC Awards Gala

Sonic Incytes was recognized as a “Company to Watch” at the 25th Annual LSBC Awards Gala, presented by Farris. This

Educational Videos

Discover the latest insights in metabolic health with our exclusive series of videos featuring renowned Key Opinion Leader, Dr. Stephen Harrison. Dive into discussions covering the most recent news and trends related to metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH), previously recognized as NAFLD and NASH.

Procedure

Patient Journey

Brand Assets / Media Kit

Official versions of the Sonic Incytes and Velacur logos.

Download All

Images